The store will not work correctly when cookies are disabled.
N-Hydroxy-2-[(4-nitro-benzyl)-phenylmethanesulfonyl-amino]-acetamide
ID: ALA53091
PubChem CID: 10762262
Max Phase: Preclinical
Molecular Formula: C16H17N3O6S
Molecular Weight: 379.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(CN(Cc1ccc([N+](=O)[O-])cc1)S(=O)(=O)Cc1ccccc1)NO
Standard InChI: InChI=1S/C16H17N3O6S/c20-16(17-21)11-18(10-13-6-8-15(9-7-13)19(22)23)26(24,25)12-14-4-2-1-3-5-14/h1-9,21H,10-12H2,(H,17,20)
Standard InChI Key: YTZCQIFAVXLXHV-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 27 0 0 0 0 0 0 0 0999 V2000
5.7042 -6.7750 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.2667 -4.6542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1792 -6.4667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6542 -6.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1292 -6.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2292 -7.0750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7500 -4.9625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0125 -6.2542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4000 -7.2917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7917 -4.9625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2667 -4.0542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1792 -5.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6125 -6.7750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1292 -5.8667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7500 -5.5667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2167 -4.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7042 -5.5667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2292 -7.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7042 -4.9625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2292 -5.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6125 -5.5667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.7042 -7.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7500 -7.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7500 -8.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7042 -8.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2292 -8.8792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 7 1 0
3 1 1 0
4 3 1 0
5 4 1 0
6 1 1 0
7 15 2 0
8 1 2 0
9 1 2 0
10 2 1 0
11 2 2 0
12 3 1 0
13 5 2 0
14 5 1 0
15 20 1 0
16 19 2 0
17 12 1 0
18 6 1 0
19 17 1 0
20 17 2 0
21 14 1 0
22 18 2 0
23 18 1 0
24 23 2 0
25 22 1 0
26 24 1 0
25 26 2 0
7 16 1 0
M CHG 2 2 1 10 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 379.39 | Molecular Weight (Monoisotopic): 379.0838 | AlogP: 1.43 | #Rotatable Bonds: 8 |
Polar Surface Area: 129.85 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.74 | CX Basic pKa: ┄ | CX LogP: 1.12 | CX LogD: 1.10 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.41 | Np Likeness Score: -1.47 |
References
1. Scozzafava A, Supuran CT.. (2000) Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties., 43 (9): [PMID:10794702] [10.1021/jm990594k] |